Canada Respiratory Syncytial Virus Diagnostics Market Size & Outlook
Related Markets
Canada respiratory syncytial virus diagnostics market highlights
- The Canada respiratory syncytial virus diagnostics market generated a revenue of USD 184.7 million in 2024 and is expected to reach USD 256.3 million by 2030.
- The Canada market is expected to grow at a CAGR of 5.8% from 2025 to 2030.
- In terms of segment, chromatographic immunoassay was the largest revenue generating product in 2024.
- Gel Microdroplets is the most lucrative product segment registering the fastest growth during the forecast period.
Respiratory syncytial virus diagnostics market data book summary
| Market revenue in 2024 | USD 184.7 million |
| Market revenue in 2030 | USD 256.3 million |
| Growth rate | 5.8% (CAGR from 2025 to 2030) |
| Largest segment | Chromatographic immunoassay |
| Fastest growing segment | Gel Microdroplets |
| Historical data | 2018 - 2023 |
| Base year | 2024 |
| Forecast period | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Direct Fluorescent Antibody (DFA) Method, Rapid Antigen Diagnostic Test (RADTs), Molecular Diagnostics, Diagnostic Imaging, Gel Microdroplets, Flow Cytometry, Chromatographic Immunoassay |
| Key market players worldwide | Becton Dickinson & Co, Novartis AG ADR, Abbott Laboratories, QuidelOrtho Corp, Thermo Fisher Scientific Inc, Bio-Rad Laboratories Inc, Roche Holding AG ADR, BioMerieux SA, Diasorin SpA, Merck KGaA, Avacta Group PLC, Siemens Healthineers AG ADR, Quest Diagnostics Inc |
Other key industry trends
- In terms of revenue, Canada accounted for 2.9% of the global respiratory syncytial virus diagnostics market in 2024.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In North America, U.S. respiratory syncytial virus diagnostics market is projected to lead the regional market in terms of revenue in 2030.
- Canada is the fastest growing regional market in North America and is projected to reach USD 256.3 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Respiratory Syncytial Virus Diagnostics Market Scope
Respiratory Syncytial Virus Diagnostics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Avacta Group PLC | View profile | 113 | Unit 20, Ash Way, Thorp Arch Estate, West Yorkshire, Wetherby, United Kingdom, LS23 7FA | https://www.avacta.com |
| Diasorin SpA | View profile | 3233 | Via Crescentino Snc, Saluggia, Vercelli, Italy, 13040 | https://www.diasoringroup.com |
| Bio-Rad Laboratories Inc | View profile | 8030 | 1000 Alfred Nobel Drive, Hercules, CA, United States, 94547 | https://www.bio-rad.com |
| QuidelOrtho Corp | View profile | 7100 | 9975 Summers Ridge Road, San Diego, CA, United States, 92121 | https://www.quidelortho.com |
| Quest Diagnostics Inc | View profile | 48000 | 500 Plaza Drive, Secaucus, NJ, United States, 07094 | https://www.questdiagnostics.com |
| Thermo Fisher Scientific Inc | View profile | 122000 | 168 Third Avenue, Waltham, MA, United States, 02451 | https://www.thermofisher.com |
| Siemens Healthineers AG ADR | View profile | 71400 | Siemensstr. 3, Forchheim, BY, Germany, 91301 | https://www.siemens-healthineers.com |
| BioMerieux SA | View profile | 13982 | Marcy l’Etoile, Lyon, France, 69280 | http://www.biomerieux.com |
| Becton Dickinson & Co | View profile | 73000 | 1 Becton Drive, Franklin Lakes, NJ, United States, 07417-1880 | https://www.bd.com |
| Abbott Laboratories | View profile | 114000 | 100 Abbott Park Road, Abbott Park, IL, United States, 60064-6400 | https://www.abbottinvestor.com |
| Merck KGaA | View profile | 62345 | Frankfurter Strasse 250, Darmstadt, HE, Germany, 64293 | https://www.emdgroup.com |
| Roche Holding AG ADR | View profile | 103605 | Grenzacherstrasse 124, Basel, Switzerland, 4070 | https://www.roche.com |
| Novartis AG ADR | View profile | 76057 | Lichtstrasse 35, Basel, Switzerland, 4056 | https://www.novartis.com |
Canada respiratory syncytial virus diagnostics market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to respiratory syncytial virus diagnostics market will help companies and investors design strategic landscapes.
Chromatographic immunoassay was the largest segment with a revenue share of 29.02% in 2024. Horizon Databook has segmented the Canada respiratory syncytial virus diagnostics market based on direct fluorescent antibody (dfa) method, rapid antigen diagnostic test (radts), molecular diagnostics, diagnostic imaging, gel microdroplets, flow cytometry, chromatographic immunoassay covering the revenue growth of each sub-segment from 2018 to 2030.
Reasons to subscribe to Canada respiratory syncytial virus diagnostics market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Canada respiratory syncytial virus diagnostics market databook
-
Our clientele includes a mix of respiratory syncytial virus diagnostics market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Canada respiratory syncytial virus diagnostics market , including forecasts for subscribers. This country databook contains high-level insights into Canada respiratory syncytial virus diagnostics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Canada respiratory syncytial virus diagnostics market size, by product, 2018-2030 (US$M)
Canada Respiratory Syncytial Virus Diagnostics Market Outlook Share, 2024 & 2030 (US$M)
Related industry reports
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
